Syncona Portfolio Ltd 13D and 13G filings for Autolus Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:44 pm Sale | 2023-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 30,734,957 11.600% | -2,792,205 (-8.33%) | Filing |
| 2024-02-13 6:41 pm Unchanged | 2023-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 33,527,162 14.400% | 0 (Unchanged) | Filing |
| 2023-02-14 10:28 am Purchase | 2022-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 33,527,162 19.700% | 14,000,000 (+71.70%) | Filing |
| 2022-02-11 12:21 pm Purchase | 2021-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 19,527,162 26.800% | 3,571,428 (+22.38%) | Filing |
| 2021-02-12 10:43 am Purchase | 2020-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 15,955,734 30.500% | 1,363,636 (+9.35%) | Filing |
| 2020-02-11 4:30 pm Purchase | 2019-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 14,592,098 32.400% | 1,000,000 (+7.36%) | Filing |